AbSci Secures Series A Funding

Apr 25, 2016 | Fundraising

PORTLAND, Ore., April 25, 2016 /PRNewswire/ — AbSci, a global leader in soluble microbial protein expression has secured $5.1M in Series A financing led by Phoenix Venture Partners (PVP). Funding will accelerate commercialization of AbSci’s...